CJC 1295: A broad model to Safe and Effective Dosage

CJC-1295 and Ipamorelin are peptides commonly used in tandem due to their synergistic effects in promoting growth hormone release. CJC-1295 stimulates the pituitary gland for growth hormone production, while Ipamorelin enhances hormone release by mimicking ghrelin. Typical dosing recommends these be administered subcutaneously, often 1000 mcg of each, daily or several times weekly, guided by healthcare supervision.

Select Wishlist

Cart Menu Button Image28Left Menu Icon
Your Cart